Get the Stockscreener App
1.70
2.41%
0.04
After Hours:
1.65
-0.05
-2.94%
Why is Reneo Pharmaceuticals Inc (RPHM) Stock down?
We've noticed a 8.00% decline in Reneo Pharmaceuticals Inc (RPHM) stock during the 2024-09-23 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
14 Dec, 2023:
Shares of Reneo Pharmaceuticals Inc (RPHM) dropped by 82.71% from $7.75 to $1.34 in the trading on Thursday, December 14, 2023. The reason why RPHM down today is due to disappointing news related to the company's pivotal STRIDE study of mavodelpar. Reneo Pharmaceuticals announced that the study, conducted in adult patients with primary mitochondrial myopathies, did not achieve its primary efficacy or secondary efficacy endpoints. This unexpected and significant setback in the clinical trial results led to a severe loss of investor confidence and a sharp decrease in RPHM's share price.
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):